anastrozole has been researched along with Epithelial Neoplasms in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A subset of patients with estrogen- or progesterone-positive platinum-resistant or platinum-refractory recurrent epithelial ovarian cancers derives clinical benefit from anastrozole, with acceptable toxicity." | 5.24 | Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer. ( Beale, PJ; Bonaventura, A; DeFazio, A; Friedlander, ML; Goh, JCH; Grant, PT; Hadley, AM; Mapagu, C; Martyn, J; McNally, OM; Mileshkin, LR; OʼConnell, RL; Scurry, J; Sjoquist, KM, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonaventura, A | 1 |
| OʼConnell, RL | 1 |
| Mapagu, C | 1 |
| Beale, PJ | 1 |
| McNally, OM | 1 |
| Mileshkin, LR | 1 |
| Grant, PT | 1 |
| Hadley, AM | 1 |
| Goh, JCH | 1 |
| Sjoquist, KM | 1 |
| Martyn, J | 1 |
| DeFazio, A | 1 |
| Scurry, J | 1 |
| Friedlander, ML | 1 |
| Esfahani, K | 1 |
| Ferrario, C | 1 |
| Le, P | 1 |
| Panasci, L | 1 |
1 trial available for anastrozole and Epithelial Neoplasms
| Article | Year |
|---|---|
Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Carcinoma, Ovarian Epi | 2017 |
1 other study available for anastrozole and Epithelial Neoplasms
| Article | Year |
|---|---|
Aromatase inhibition in relapsing low malignant potential serous tumours of the ovary.
Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Carcinoma, Ovarian Epithelial; Female; Humans; | 2014 |